Autopsy report · NCT02860130

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

“Study halted due to low recruitment, unrelated to safety or efficacy reasons”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 1 year 8 months before it stopped.
• 34 participants enrolled.
• Results were posted on the registry 2 years 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Vantive Health LLC

Sponsor type

Industry

Conditions

Regional Citrate Anticoagulation (RCA); Continuous Renal Replacement Therapy (CRRT); Acute Kidney Injury

Interventions

Prismocitrate 18; No Anticoagulation

Participants

34

Sites

12

Countries

Canada, United States

Trials that died the same way

• Obesity Hypoventilation Syndrome Prevalence Study
  “This study was stopped due to low recruitment.” (87% match in meaning)
• Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)
  “Study was stopped due to insufficient recruitment.” (84% match in meaning)
• Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
  “The study was stopped due to recruitment difficulties” (84% match in meaning)
• Comparing Palliative Radiotherapy With or Without Carboplatin
  “The study was stopped due to insufficient recruitment.” (84% match in meaning)
• Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor
  “Study halted due to slow recruitment” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.